Published in N Engl J Med on October 02, 1986
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax (1998) 1.58
Management of respiratory complications in clinical dental practice. Pathophysiological and technical considerations. Anesth Prog (1990) 1.43
Aerosol therapy in Canada: what are the standards? CMAJ (1993) 1.38
Avoiding asthma fatalities in family practice. Can Fam Physician (1989) 0.96
Asthma: 2. Trends in pharmacologic therapy. CMAJ (1987) 0.90
Prescribing drugs for the elderly: reaching therapeutic goals. Can Fam Physician (1986) 0.88
Bioequivalence of generic aerosol bronchodilators: what are the issues? CMAJ (1989) 0.85
Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax (1997) 0.83
Exposure to an aeroallergen and respiratory arrest in patients with asthma. N Engl J Med (1991) 0.78
Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial. Open Respir Med J (2009) 0.75
Spacers and reservoirs in delivery systems. West J Med (1989) 0.75
Chest diseases: inhaled treatment of asthma. West J Med (1990) 0.75
Oral vs inhaled asthma therapy. Pros, cons and combinations. Drugs (1996) 0.75
Treatment of Difficult Asthma: What do you do when asthma doesn't respond to therapy? Can Fam Physician (1991) 0.75
Strategies in managing asthma. West J Med (1989) 0.75
Regional distribution of inspired gas in the lung. J Appl Physiol (1966) 3.65
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest (1990) 2.67
Regional distribution of ventilation and perfusion as a function of body position. J Appl Physiol (1966) 2.20
Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax (1978) 2.05
Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy. J Pediatr (1999) 2.03
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.88
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85
Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol (1976) 1.83
Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis (1988) 1.68
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Optimal delivery of aerosols from metered dose inhalers. Chest (1981) 1.59
Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest (1983) 1.50
Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis (1990) 1.50
The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis (1978) 1.48
Relationship between acute respiratory illness and air pollution levels in an industrial city. Am Rev Respir Dis (1977) 1.46
Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers--a continuing controversy. Am Rev Respir Dis (1993) 1.43
Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis (1977) 1.43
Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol (1989) 1.40
Use of scintillation camera and 135-xenon for study of topographic pulmonary function. Respir Physiol (1968) 1.39
Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis (1989) 1.33
Deposition and fate of aerosolized drugs. Chest (1978) 1.29
Are active and passive smoking harmful? Determining causation. Chest (1985) 1.29
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.27
Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest (1993) 1.27
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects. Chest (1978) 1.22
Nasal ciliary ultrastructure and function in patients with primary ciliary dyskinesia compared with that in normal subjects and in subjects with various respiratory diseases. Am Rev Respir Dis (1984) 1.17
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med (1988) 1.16
Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther (1978) 1.16
Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest (1978) 1.15
Gastroesophageal reflux and chronic respiratory disease. Am Rev Respir Dis (1984) 1.13
Aerosol penetration into the lung; influence on airway responses. Chest (1981) 1.13
Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis (1982) 1.12
Alveolar macrophage/peripheral blood monocyte-derived factors modulate proliferation of primary lines of human lung fibroblasts. J Leukoc Biol (1987) 1.09
Lung epithelial permeability: relation to nonspecific airway responsiveness. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.09
Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest (1979) 1.07
The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome. Chest (1980) 1.03
Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Am Rev Respir Dis (1979) 1.03
Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax (1988) 1.00
Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med (1997) 0.97
Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics. Lung (1978) 0.95
Health effects of urea formaldehyde foam insulation: evidence of causation. CMAJ (1986) 0.95
The dyskinetic cilia syndrome; abnormal ciliary motility in association with abnormal ciliary ultrastructure. Chest (1981) 0.95
Effects of exercise and eucapnic hyperventilation on bronchial clearance in man. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.93
Chronic cough and gastroesophageal reflux. CMAJ (1989) 0.93
Primary ciliary dyskinesia: evaluation and management. Pediatr Pulmonol (1988) 0.93
Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am Rev Respir Dis (1980) 0.92
Effect of TLV levels of SO2 and H2 SO4 on bronchial clearance in exercising man. Arch Environ Health (1978) 0.91
Steady state measurement of regional ventilation to perfusion ratios in normal man. J Clin Invest (1966) 0.91
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Aerosols as diagnostic tools. J Aerosol Med (1994) 0.90
Nasal polyposis: in search of a viral etiology using DNA hybridization. J Otolaryngol (1991) 0.89
Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma. J Aerosol Med (1999) 0.89
Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics (2001) 0.88
Are nebulizers obsolete for administering asthma medications to infants and children? Pediatr Pulmonol (1993) 0.88
Ciliary function, cell viability, and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea. Chest (1992) 0.88
UFFI dust: nonspecific irritant only? Chest (1982) 0.88
Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications. Chest (1987) 0.87
Control of asthma. Can Med Assoc J (1982) 0.86
Activation of nasal cilia in immotile cilia syndrome. Am Rev Respir Dis (1979) 0.86
Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med (1996) 0.86
A controlled trial of ambroxol in chronic bronchitis. Chest (1987) 0.86
Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers. Am J Respir Crit Care Med (1999) 0.85
Dipyridamole - is it a bronchodilator? Eur J Respir Dis (1981) 0.85
Suction excision biopsy for diffuse pulmonary disease. Chest (1973) 0.84
Mechanism of bronchodilator effect in chronic airflow limitation. CMAJ (1991) 0.84
Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation? Eur Respir J (2003) 0.84
Sulfur dioxide and tracheobronchial clearance in man. Arch Environ Health (1975) 0.84
Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med (1999) 0.84
Is theophylline obsolete? Chest (1990) 0.83
Acute exposure of symptomatic steelworkers to sulphur dioxide and carbon dust: effects on mucociliary transport, pulmonary function, and bronchial reactivity. Br J Ind Med (1984) 0.83
Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. Am Rev Respir Dis (1991) 0.82
Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration. J Chromatogr B Biomed Appl (1994) 0.81
Evaluation of disodium cromoglycate in intrinsic and extrinsic asthma. Am Rev Respir Dis (1972) 0.81
Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Crit Care Med (1994) 0.80
A randomized controlled trial on the effect of inhaled corticosteroids on airways inflammation in adult cigarette smokers. Chest (1999) 0.80
Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma. Chest (1994) 0.79
Effect of pregnancy on airway responsiveness and asthma severity. Relationship to serum progesterone. Am Rev Respir Dis (1991) 0.79
Methodologic considerations in mucociliary clearance and lung epithelial absorption measurements. Eur J Nucl Med (1987) 0.79
Asthma terminology: troubles in wordland. Am Rev Respir Dis (1986) 0.78
Ciliary defects associated with the development of bronchopulmonary dysplasia. Ciliary motility and ultrastructure. Am Rev Respir Dis (1984) 0.78
Regional distribution and lung clearance mechanisms in smokers and non-smokers. Inhaled Part (1970) 0.78
Nasal cilia in normal man, primary ciliary dyskinesia and other respiratory diseases: analysis of motility and ultrastructure. Eur J Respir Dis Suppl (1983) 0.78